October 2019 FDA Recall Drug by Nephron Pharmaceuticals Corporation Dba Nephron Sterile Compounding Center
D-0154-2020 - Incorrect labeling

This Class III drug recall was voluntarily initiated by Nephron Pharmaceuticals Corporation Dba Nephron Sterile Compounding Center on October 21, 2019 for the product Drug. The FDA reported the reason for recall as incorrect labeling. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0154-2020

Reason for Recall
Incorrect labeling: Incorrect or missing lot and/or exp date
Initiated
10-21-2019
Reported
11-06-2019
Quantity
19,390 syringes

Recall Profile & Regulatory Data

Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Nephron Pharmaceuticals Corporation dba Nephron Sterile Compounding Center
Nationwide in the U.S.
PF-Succinylcholine Chloride Injection, USP 20 mg/mL (200 mg/10 mL), Rx Only, Single-Dose Container, 5 x 10 mL pre-filled syringes, Nephron 503B Outsourcing Facility 4500 12th St. Ext West Columbia, SC 29172, NDC 69374-919-10.

Batch or Lot Expiration Information

Lot# Lots: SU9079A, SU9079B, Exp 4/5/2020